NDC 50102-120-01 - AUBRA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-120
- Requested NDC
- 50102-120-01
- Package NDCs from labels
- 50102-120-00, 50102-120-01, 50102-120-48, 50102-120-10, 50102-120-03
- Manufacturer
- Afaxys Pharma, LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AUBRA - Afaxys Pharma, LLC | Mylan Laboratories Limited | Afaxys Pharma, LLC | Mylan Laboratories Limited | 2021-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50102-120-03 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-02-17 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-03 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
| 50102-120-48 | 2023-01-30 | Aubra® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.1 mg/0.02 mg) |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-120-00 | EA - Each | 50102-120 | d9bee6d9-aa9d-4898-93de-438dae2bb869 | 1 | 2022-06-06 |
| 50102-120-01 | EA - Each | 50102-120 | 8b796782-496f-4ed0-b025-66127b0fc3f9 | 1 | 2013-11-04 |
| 50102-120-03 | EA - Each | 50102-120 | c2265cdf-ed8f-437d-9e4b-312af0119f71 | 1 | 2017-09-11 |
| 50102-120-10 | EA - Each | 50102-120 | 5c1fb698-e254-4b92-8ed9-eb87d3604632 | 1 | 2017-09-11 |
| 50102-120-48 | EA - Each | 50102-120 | 8a66d499-33ea-4443-a859-d114a3240255 | 1 | 2013-11-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calamine | CALAMINE, PRAMOXIND HCL | Perrigo Direct, Inc | 54a20ec9-ab86-4410-af94-e04393e9d4b3 | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Meijer, Inc. | 6b369ef2-fd54-4931-a9eb-0fb42834c2ef | 2026-02-19 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Target Corporation | d4ee05c8-ae62-45df-8783-1ed57fa030ec | 2026-02-18 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Topco Associates LLC | 2b32e720-ac71-4d60-bc06-e28a00f8a450 | 2026-02-13 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | CALAMINE, PRAMOXINE HCL | Topco Associates LLC | 15d1ae3f-509c-4e6b-8f0c-cf9265680358 | 2026-02-13 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Major Pharmaceuticals | c25be68d-834a-4959-8d47-01ec789406ba | 2026-02-04 | Warnings, Adverse reactions | 1K09F3G675 |
| Levonorgestrel | LEVONORGESTREL | YYBA Corp | 49008f10-8a70-3c08-e063-6294a90a44a3 | 2026-02-03 | Warnings | 5W7SIA7YZW |
| Aquavit 1 | AQUAVIT 1 | Uriel Pharmacy Inc. | 2354fcfc-05a2-444a-ace4-b3df61413157 | 2026-02-02 | Warnings | 1K09F3G675 |
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 44fbc5ae-5682-471f-a12a-955e8b4d233a | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 423D2T571U 5W7SIA7YZW |
| Norethindrone Acetate and Ethinyl Estradiol | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 5a44f7a2-45f1-4d28-b9fb-61d9f2456422 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Hailey 1.5/30 | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | 021df70a-0c37-4237-a2f7-2597ff6d41f5 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Calamine | CALAMINE | AMERISOURCE BERGEN | 90d9d908-57ea-4062-ade0-8a4888939c91 | 2026-01-29 | Warnings, Adverse reactions | 1K09F3G675 |
| Norethindrone Acetate and Ethinyl Estradiol | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Glenmark Pharmaceuticals Inc., USA | cf549b5a-2707-4020-9f94-dab1260e1664 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| ZAFEMY | NORELGESTROMIN AND ETHINYL ESTRADIOL | AvKARE | fbbd12dd-c538-2869-e053-6294a90a1a38 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| First Chakra (Root) 7301 | FIRST CHAKRA (ROOT) | Professional Complementary Health Formulas | 61eb1bbe-6675-4369-b852-18975e6b08c7 | 2026-01-08 | Warnings | 1K09F3G675 |
| Third Chakra (Solar Plexus) 7303 | THIRD CHAKRA (SOLAR PLEXUS) | Professional Complementary Health Formulas | eea89c37-ab87-4cc7-8dfc-e7f42a580dd9 | 2026-01-08 | Warnings | 1K09F3G675 |
| Fyavolv | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | Lupin Pharmaceuticals, Inc. | 772c86d7-10a4-48c5-8c19-f8aac68f5ab4 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | 423D2T571U |
| Dermagesic | PRAMOXINE HCL, ZINC OXIDE, CALAMINE | Llorens Pharmaceutical International Division | bbff6b53-29da-45c1-8ccd-3e9df7f250e0 | 2025-12-31 | Warnings | 1K09F3G675 |
| BABY ANTI MONKEY BUTT DIAPER RASH | ZINC OXIDE, CALAMINE | Clarion Brands, LLC | e4424d74-f89c-5943-42e8-bf3a38e68619 | 2025-12-23 | Warnings | 1K09F3G675 |
| Her Style | LEVONORGESTREL | Ingenus Pharmaceuticals, LLC | 6e631755-b7c5-4a3a-b46d-f66b4ceedb1c | 2025-12-05 | Warnings | 5W7SIA7YZW |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.